MAPT and early-onset autosomal dominant Alzheimer disease: For instance, COVID-19 has been linked to the activation of the NLRP3 inflammasome, tau aggregation, neurodegeneration, and elevated levels of amyloid-beta deposition and cerebrospinal fluid markers such as neurofilament light chain, and tau, suggesting ties to Alzheimer’s disease pathology [15].